These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3165141)

  • 1. [Clinical features and hematological factors relating to outcome of adult patients with acute myeloid leukemia who achieved complete remission].
    Karasawa M; Tukamoto N; Nogiwa E; Yamauchi H; Iwata N; Omine M; Maekawa T; Murakami H; Nemoto K; Miyawaki S
    Rinsho Ketsueki; 1988 Mar; 29(3):330-5. PubMed ID: 3165141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute leukemia in the elderly patient. Forty case reports].
    Laatiri MA; Chehata S; Ajmi F; Amouri A; Bouaouina N; Saad A; Ennabli S
    Tunis Med; 2000; 78(8-9):503-7. PubMed ID: 11190727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center].
    Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A
    Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlative patterns of neutrophil and platelet counts during very early remission of acute myeloblastic leukemia.
    Ventura GJ; Drewinko B; Keating MJ
    Hematol Pathol; 1987; 1(2):113-6. PubMed ID: 3504433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical-hematological findings in 58 acute leukemias].
    Müller D
    Med Klin; 1969 Jan; 64(1):13-7. PubMed ID: 5249931
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia.
    Kerridge I; Lowe M; Seldon M; Enno A; Deveridge S
    Arch Intern Med; 1997 Aug 11-25; 157(15):1753-7. PubMed ID: 9250237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can the course of an acute leukemia be predicted?].
    Heim M; Albert WK; Schäfer W; Wahrendorf J; Queisser W
    Med Klin; 1981 Sep; 76(19):537-40. PubMed ID: 6944596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial cells in patients with acute myeloid leukemia.
    Wierzbowska A; Robak T; Krawczyńska A; Wrzesień-Kuś A; Pluta A; Cebula B; Smolewski P
    Eur J Haematol; 2005 Dec; 75(6):492-7. PubMed ID: 16313261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The long-term persistence of cell clone 47,XX,+I(1Q) in a female patient with multiyear complete clinico-hematological remission of acute myeloid leukemia].
    Kobzev IuN; Udovichenko AI; Aseeva EA; Domracheva EV; Zakharova AV; Diachenko LV; Kuchma IuM
    Ter Arkh; 1997; 69(7):59-61. PubMed ID: 9424763
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and laboratory features of the myeloid and lymphocytic leukemias.
    Rowe JM
    Am J Med Technol; 1983 Feb; 49(2):103-9. PubMed ID: 6573132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency surgical treatment for patients with acute leukemia.
    Koretz MJ; Neifeld JP
    Surg Gynecol Obstet; 1985 Aug; 161(2):149-51. PubMed ID: 3860992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
    Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
    Rizzieri DA; O'Brien JA; Broadwater G; Decastro CM; Dev P; Diehl L; Beaven A; Lagoo A; Gockerman JP; Chao NJ; Moore JO
    Cancer; 2009 Jul; 115(13):2922-9. PubMed ID: 19452542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Views on the treatment of acute myeloid leukemia in adults].
    Mód A; Poros A; Hollán Z
    Orv Hetil; 1986 Mar; 127(12):683-8. PubMed ID: 3457352
    [No Abstract]   [Full Text] [Related]  

  • 18. Early discharge from hospital after consolidation chemotherapy in acute myeloid leukemia in remission: febrile neutropenic episodes and their outcome in a resource poor setting.
    Naithani R; Kumar R; Mahapatra M; Agrawal N; Mishra P
    Haematologica; 2008 Sep; 93(9):1416-8. PubMed ID: 18603560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Supportive therapy with thrombocyte concentrates in patients with acute leukemia].
    Höcker P; Hinterberger W; Lechner K; Wagner A; Panzer S
    Beitr Infusionther Klin Ernahr; 1987; 18():115-22. PubMed ID: 3481544
    [No Abstract]   [Full Text] [Related]  

  • 20. To treat or not to treat acute granulocytic leukemia. II.
    Boggs DR; Wintrobe MM; Cartwright GE
    Arch Intern Med; 1969 May; 123(5):568-70. PubMed ID: 5252617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.